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Abstract
Mutations in the Drosophila trol gene cause cell cycle arrest of neuroblasts in the larval brain. Here, we show that trol encodes the Drosophila
homolog of Perlecan and regulates neuroblast division by modulating both FGF and Hh signaling. Addition of human FGF-2 to trol mutant brains
in culture rescues the trol proliferation phenotype, while addition of a MAPK inhibitor causes cell cycle arrest of the regulated neuroblasts in
wildtype brains. Like FGF, Hh activates stem cell division in the larval brain in a Trol-dependent fashion. Coimmunoprecipitation studies are
consistent with interactions between Trol and Hh and between mammalian Perlecan and Shh that are not competed with heparin sulfate. Finally,
analyses of mutations in trol, hh, and ttv suggest that Trol affects Hh movement. These results indicate that Trol can mediate signaling through
both of the FGF and Hedgehog pathways to control the onset of stem cell proliferation in the developing nervous system.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
A powerful system for the study of cell cycle control in a
developmental context is the regulated neuroblasts in the larval
nervous system of Drosophila melanogaster. A distinct subset
of neuroblasts in the larval brain lobes are mitotically quiescent
when the larva hatches and begin to initiate cell division at
about 8–10 h posthatching (ph) (Caldwell and Datta, 1998;
Datta, 1995; Ebens et al., 1993; Hofbauer and Campos-Ortega,
1990; Truman and Bate, 1988; White and Kankel, 1978). The
initiation of neuroblast division both in vivo and in vitro re-
quires the hormone ecdysone (Datta, 1999; Park et al., 2001;
Y.P. and S.D. unpublished results). Levels of ecdysone in vivo
appear to be controlled in part by the activity of the homeobox
gene even-skipped (Park et al., 2001). The activation of pro-
liferation by quiescent neuroblasts is blocked in animals mu-
tant for the severe loss-of-function allele trolsd (Datta, 1995).
We have previously shown that the neuroblasts in trolsd mu-
tants are arrested in late G1 (Caldwell and Datta, 1998). These
and other studies (Ebens et al., 1993; Park et al., 1998) suggest
a model where the initiation of cell division in quiescent
neuroblasts requires a series of developmental signals that
stimulate progression in a stepwise fashion from arrest in
G0/G1 to active proliferation.
Secreted signaling molecules provide critical informa-
tion for the growth and patterning of tissues during the
development of multicellular organisms. Molecules of the
Fibroblast Growth Factor (FGF) family provide cues that
regulate the proliferation of many different cell types, in
organisms ranging from Drosophila to man (reviewed in
Powers et al., 2000). Similarly, secreted proteins of the
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Hedgehog (Hh) family also modulate precursor cell division
(reviewed in Hammerschmidt et al., 1997; Nybakken and
Perrimon, 2002). In Drosophila, a single FGF-2 homolog is
encoded by the branchless (bnl) locus (Sutherland et al.,
1996) and the only Hedgehog protein is encoded by the
hedgehog (hh) gene (Nusslein-Volhard and Wieschaus,
1980). Bnl and Hh are excellent candidates for the coordi-
nation of developmental processes with cell cycle control.
Interactions of FGFs with heparan sulfate proteoglycans
(HSPGs) found in the extracellular matrix (reviewed in
Powers et al., 2000) are required for the binding of FGF-2
to its high affinity receptor (Yayon et al., 1991). A specific
HSPG that modulates formation of the tripartite FGF-2-
receptor–HSPG complex is the basal lamina proteoglycan
Perlecan (Aviezer et al., 1994; Vigny et al., 1988; White-
lock et al., 1996). Interactions of the mammalian Hedgehog
protein Sonic Hedgehog (Shh) with heparin sulfate have
recently been published (Rubin et al., 2002).
Genetic analyses have uncovered a role for sugar struc-
ture and proteoglycans in mediating Hh signaling and con-
firmed the requirement for HSPGs in modulating FGF sig-
naling (reviewed in Baeg and Perrimon, 2000; Perrimon and
Bernfield, 2000; Selleck, 2001). For example, mutations in
a GlcA/GlcNac transferase (Tout-velu or Ttv), an enzyme
that synthesizes the heparan sulfate side chains of HSPGs, is
required for Hh signaling (Bellaiche et al., 1998; The et al.,
1999). The identity of the protein core of the HSPG(s)
implicated in Hedgehog signaling is unknown.
Here, we demonstrate that the trol locus encodes a predicted
protein highly homologous to mammalian Perlecans (mPerle-
can). trol expression is detected at all developmental stages and
in many developing tissues. As predicted by analogy to mPer-
lecans, mutations in trol reduce signaling by Bnl and the FGF
receptor homolog Breathless (Btl) (Klambt et al., 1992) in
vivo. Addition of human FGF-2 to trol mutant brains in culture
rescues the trol proliferation phenotype, while addition of a
MAPK inhibitor causes cell cycle arrest of the regulated neu-
roblasts in wildtype brains. We show that Hh also acts as an
activator of stem cell division in the larval brain, and similarly
to Bnl, the ability of Hh to promote neuroblast division de-
pends on the Trol protein. Initiation of neuroblast proliferation
depends on Hh signaling through Trol during first instar. Co-
immunoprecipitation studies are consistent with interactions
between Trol and Hh, and between mPerlecan and Shh, which
are not competed with heparin sulfate. Finally, analyses of
mutations in trol, hh, and ttv suggest that Trol affects Hh
movement or binding as does a mutation in hh that results in
production of a mutant protein.
Materials and methods
Mutagenesis
y w males were mutagenized with 12.5 mM DEB and
mated to produce F1 males carrying independent mutations.
The presence of new trol alleles was assayed in a comple-
mentation test, stocks were established, and all new trol
alleles were “cleaned” of possible secondary mutations by
three generations of crossing over. The trol alleles were
followed through the recombination process by the y and w
markers and by lethality.
Nucleic acid molecular biology
Genomic DNA and RNA isolation and RT-PCR were
done by using standard techniques. Primers used for RT-
PCR were positioned so that they flanked a predicted intron,
thus permitting us to distinguish between genomic DNA
and cDNA products. PCR and sequencing primers were
designed by using either the Operon Web site or VectorNT
program; primer sequences are available upon request. In
situ hybridization was carried out by using standard tech-
niques. Double-stranded RNA for RNAi was prepared and
injected as described previously (Misquitta and Paterson,
1999).
Protein analysis
Extracts (Paulsson et al., 1987) were prepared from first
and third instar larvae, size selected using Microcon-100
concentrators (Millipore), and the protein concentration de-
termined with a BCA Protein Assay Kit (Pierce). Samples
were immunoblotted with anti-mPerlecan Domain IV anti-
body (Chemicon). Coimmunoprecipitations were done es-
sentially as described in Whitelock et al. (1996) with the
following modifications. For FGF-2-Trol coimmunoprecipi-
tations, 0.25 cu 125I-FGF-2 was added to 500 g of 100
kDa extract, 125I-FGF-2 was visualized by using SDS–
PAGE. For Hh-Trol coimmunoprecipitations, third instar
hs-hh larvae were induced at 37°C for 30 mins, and extract
was prepared as described above. Extracts were incubated
with antibody for 10 h at 4°C and complexes harvested with
preadsorbed Protein G beads overnight. Samples were an-
alyzed by Western blotting. For mPerlecan-Shh coimmuno-
precipitations, conditioned medium from highly confluent
primary SJL/J or BALB/C murine CVE lines (Sapatino et
al., 1993) was concentrated 10- to 20-fold by using Micro-
con filters. Concentrated medium was incubated with anti-
body for 10 h at 4°C, and complexes harvested with pread-
sorbed Protein G beads for 10 h and examined by Western
analysis.
Genetic interactions
Animals were reared at 25°C on standard medium. Lar-
vae were synchronized by collection of newly hatched an-
imals in 1-h windows. BrdU incorporation and visualiza-
tion, neuroblast quantitation and rescue by induced
expression of cycE were carried out by using established
procedures (Caldwell and Datta, 1998; Datta, 1995). Stan-
dard error of the mean was calculated and the significance
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of differences in mean response between populations was
evaluated by Student’s t test. LacZ expression was followed
by fixing larval brains for 10 mins in a 1% gluteraldehyde
solution and then using a standard -galactosidase activity
stain.
Culture studies
In vitro culture of larval brain explants was carried out as
previously described with and without the addition of 10
nM human FGF-2 (Sigma) or 10 M PD98059 to the
culture medium. Studies were run in quadruplicate by using
BrdU incorporation to analyze the number of S-phase neu-
roblasts. The percent of samples with numbers of dividing
neuroblasts in the control range was calculated for each set
and reported along with the SEM for each experimental
condition. Statistical significance was determined by using
Student’s t test.
Results
Identification of additional trol alleles and analysis of
neuroblast proliferation
A chemical mutagenesis with diepoxybutane (DEB) was
used to generate new alleles of trol. Approximately 2000
mutagenized F1 males produced three independent trol al-
leles: trol4, trol5, and trol6. All are homozygous lethal.
Screening of an additional 150 X chromosome lethal lines
from a previous DEB mutagenesis (D.N. Dimlich and D.R.
Kankel, unpublished observations) resulted in the identifi-
cation of two more trol alleles: trol7 and trol8.
The activation of neuroblast proliferation in animals mu-
tant for four trol alleles was assayed by counting the number
of neuroblasts labeled by BrdU from 16–20 h ph as previ-
ously described (Datta, 1995). trol4, trol5, trol6, and trolS1
all produced a defective neuroblast proliferation phenotype
at late first instar (Fig. 1). The ability of induced cyclin E
expression to rescue the proliferation phenotype of trol4,
trol5, trol6, and trolS1 was assayed by BrdU incorporation as
described in Caldwell and Datta (1998). In all trol alleles
examined, cyclin E expression was able to rescue the mutant
proliferation phenotype (Fig. 1). Proliferation was never
observed in the ventral nerve cord, nor was overprolifera-
tion observed in the lobes.
Mutations in trol lead to changes in DNA and mRNA
sequence and protein abundance of the putative
Drosophila perlecan homolog
Previous genetic analyses indicated that trol maps to
3A3-5 on the X chromosome (Datta and Kankel, 1992;
Shannon et al., 1972). Genetic mapping and sequence in-
formation from the Drosophila genome project suggested
that trol might correspond to GC7981, which comprises 44
exons that add up to a 13.5-kb open reading frame. The
predicted GC7981 protein is about 450 kDa in size and has
significant sequence identity to human Perlecan (Murdoch
et al., 1992) in domains III (34%), IV (24%), and V (30%)
(Fig. 2A), whereas no significant similarity is found to
domains I and II.
RFLP, PCR, and sequence analysis of the existing trol
alleles were carried out to identify lesions in the predicted
Drosophila perlecan gene. Sequence analysis of genomic
DNA from the X-ray-induced allele trolb22 revealed a single
Fig. 2. Molecular analysis of the Drosophila Perlecan homolog. (A) Com-
parison of predicted amino acid structure between human and Drosophila
Perlecan proteins. There is no significant similarity between human do-
mains I and II and the Drosophila protein. The position of deletions in trol7
and trolb22 are indicated on the Drosophila protein. (B) RFLPs in PCR
products of DNA derived from trol mutant animals. PCR products from the
trol region derived from genomic DNA from trolb22 (3), and control y w (1)
and CS strains (2) were digested with AvalI. PCR products from trol7 (5)
and the parental y w line (4) were digested with ApoI. (C) Comparison of
predicted protein sequence produced by the trol7 and trolb22 alleles to y w
controls as derived from sequence analysis of the regions containing the
RFLPs shown in (B). Altered amino acids are shown in bold type; stop
codons are indicated by asterisks. (D) Western analysis of trol mutants.
Top panel probed with anti-mPerlecan domain IV antibody. (1) y w, (2)
trolsd, (3) trol7, (4) trol8, (5) trolb22. Bottom panel probed with 10E4
antibody. (6) y w, (7) trolb22.
Fig. 1. Rescue of trol proliferation defects by induced CycE expression. A
significant decrease in the number of S-phase neuroblasts/brain lobe is
observed in samples mutant for each of four trol alleles compared with
controls. Heat shock induction of a cycE transgene increases the number of
BrdU-labeled neuroblasts to wildtype levels.
249Y. Park et al. / Developmental Biology 253 (2003) 247–257
base pair deletion in domain V at position 117818 in the
genomic sequence (Flybase numbering)/11821 in the puta-
tive mRNA sequence. The deletion results in a predicted
frame shift and truncation of the protein from 450 to 400
kDa (Fig. 2B and C). The single base deletion is also
observed in RT-PCR fragments derived from larval RNA,
indicating that the trolb22 lesion lies within the transcribed
sequence. Sequence comparison of a second independent
allele, trol7, and the parental y w chromosome in domain IV
revealed a 25-base pair deletion in trol7 from 127431 to
127456 in the genomic sequence/7966-7991 in the predicted
mRNA sequence resulting in a frame shift and truncation of
the predicted protein from 450 to 267 kDa (Fig. 2B and C).
Analysis of two additional independent trol alleles, trol6 and
trol8, also led to the identification of molecular lesions
within the GC7981 coding sequence (data not shown).
The Perlecan protein in third instar trol mutant larvae
was analyzed by Western blot of a native gel (Fig. 2D) using
either an anti-mPerlecan domain IV antibody or 10E4, an
antibody specific for heparan chains. A total of 100 g of
size-fractionated larval protein was isolated from animals
mutant for each of four independent trol alleles, and the
parental y w strain for two of the alleles was analyzed. Third
instar trolb22 extracts produced multiple bands compared
with control y w extracts when probed with either antibody.
Extracts from trolsd, trol7, and trol8 had greatly decreased
anti-mPerlecan immunoreactivity. Consonant with the rela-
tive severity of the mutations, extract from trol8 animals
showed more staining than did extracts from either trolsd or
trol7. The predicted protein truncations for Trolb22 and Trol7
proteins are not observed, presumably due to separation
based on shape and charge as well as by size, and perhaps
additionally due to instability of the Trol7 protein.
Due to the large size of the predicted trol open reading
frame, RNAi assays were carried out to further verify that
Drosophila Perlecan protein is the product of the trol locus.
Double-stranded RNA was made from an 1-kb section at
the 3 end of the putative trol cDNA, covering multiple
exons. Double-stranded RNA, single-stranded sense RNA,
and buffer were used to inject wildtype embryos, and the
proliferation phenotype of the resulting larvae was assayed
as previously described (Caldwell and Datta, 1998; Datta,
1995; Park et al., 1998, 2001). When injected with double-
stranded RNA from the putative trol cDNA, 45% of larvae
had a proliferation defect compared with only 5% of the
single-stranded or buffer-injected animals, further evidence
that trol is the Drosophila perlecan gene. While this manu-
script was in revision, a paper by Voigt et al. (2002) was
published, independently confirming that the trol locus en-
codes the Drosophila perlecan gene.
mRNA corresponding to the perlecan orf is expressed in
the embryo and larval tissues
trol expression was monitored by using a combination of
cDNA library screening, in situ hybridization, and RT-PCR.
A 2-kb clone representing the 3 end of the trol message
was isolated from a 0- to 24-h embryonic cDNA library
(Huen, unpublished observations). RT-PCR studies showed
that trol mRNA is expressed in unfertilized eggs (data not
shown) and all stages of the life cycle (Fig. 3). The trol
message is also present in first, second, and third instar
brains and the heads, ovaries, and testes of adult flies. In situ
hybridization (data not shown) with probes to domain IV-
and domain V-encoding regions confirmed trol expression
in the developing embryo and imaginal discs. These results
correlate with the expression pattern previously observed
for the Drosophila perlecan mRNA corresponding to do-
main V (Friedrich et al., 2000). In addition, we see strong
staining in the fat body cells adjacent to the salivary glands
(data not shown). These findings have been confirmed by
Voigt et al. (2002), who also describe trol expression in
small clusters of cells on the medial side of the brain lobes
but not the optic lobe region of the late third instar larval
brain. It should be noted that the larval brain expression they
describe is observed approximately 3 days after the onset of
the trol neuroblast proliferation phenotype.
Mutations in the FGF pathway show genetic interactions
with trolb22
The mPerlecans function as coreceptors for FGF signal-
ing. Since identification of members of a signaling pathway
by detection of dominant enhancement of a sensitized mu-
tant background is well established (Simon et al., 1991), we
tested mutations in the FGF pathway in combination with
trol to determine whether trol also functions in the FGF
pathway in Drosophila. Genetic interaction studies were
done with strong alleles of branchless (bnlPI, bnl06916),
breathless (btlLG19), and heartless (htlAB42) and a weak trol
allele, trolb22. trolb22 mutants have barely sufficient trol
activity to produce normal neuroblast division, and any
further decrease in trol function results in a neuroblast
proliferation phenotype (Park et al., 1998, 2001). btl and htl
encode FGF receptor homologs (Beiman et al., 1996; Gis-
selbrecht et al., 1996; Klambt et al., 1992), with btl encod-
ing the receptor for Bnl. The ligand for Htl is currently
unknown. bnl06916 or btlLG19 but not htlAB42 dominantly
enhance the trol phenotypes in trolb22 mutant animals as
Fig. 3. Expression of trol. RT-PCR from CS mRNA isolated from first
instar (1), second instar (2), and third instar larvae (3), as well as brains
from first instar (4), second instar (5), and third instar larvae (6), and adult
ovaries (7), testes (8), and heads (9). Lane 10 has no cDNA added; lane 11
uses a trol cDNA template. Primers were chosen so that they bracketed an
intron of 100 bases to allow differentiation between products from cDNA
and genomic DNA.
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shown by the production of a neuroblast proliferation phe-
notype visible as a shift in distribution of the numbers of
samples from centering around 1.0 to lower values as nor-
malized to controls (Fig. 4A; and data not shown). As
expected, all larvae mutant for trolb22 alone have normal
neuroblast proliferation (n  18). In contrast, 68% of
trolb22; bnl06916/ samples and 89% of trolb22; btlLG19/
samples have dramatically fewer S-phase neuroblasts (n 
19/28 and n 25/28, respectively). All of trolb22; htlAB42/
samples, however, show normal neuroblast proliferation (n
 23) as do all control bnl06916/, btlLG19/ and htlAB42/
samples (n  18, n  24, and n  20, respectively).
Dominant enhancement of the neuroblast proliferation phe-
notype of a second independent trol allele, trol4, was also
observed upon heterozygosity by bnl06916 or btlLG19 but not
htlAB42 (data not shown).
FGF-2 rescues a weak trol neuroblast phenotype in
culture
The ability of human FGF-2 to rescue the neuroblast
phenotype of a trol mutant, trol8, was investigated by using
explant cultures (Fig. 4B). trol8 has a neuroblast prolifera-
tion defect in vivo in approximately 23% of samples tested
and normal neuroblast proliferation in the remaining 77%
(Park et al., 2001). In culture, trol8 brains had normal
proliferation in 8  1% (3/38 total) of the samples, while
CS controls had normal proliferation in 24  4% (16/65
total) of the samples. When cultured in the presence of 10
ng/ml FGF-2, however, 28  3% of trol8 brains (18/68
total) now show normal proliferation compared with 26 
5% (21/79 total) of CS brains also cultured with FGF-2.
Addition of the MAPK inhibitor PD98059 at first instar
blocks activation of neuroblast division
The decreased number of S-phase cells when Bnl signal-
ing was compromised could have been due to fewer neuro-
blasts being determined during embryogenesis. To elimi-
nate this possibility, we blocked activation of the
downstream effector MAPK in first instar wildtype animals
and assayed neuroblast proliferation. The MAPK inhibitor
PD98059 blocks MAPK activation in Aplysia, mammals,
and insects (Burdon et al., 1999; Cook et al., 1999; Martin
et al., 1997; Riehle and Brown, 1999). To show PD98059
functions in Drosophila, we cultured third instar eye discs in
10 M PD98059 and assayed for lack of MAPK activity by
immunohistochemistry with the doubly phosphorylated-
MAPK antibody. After a 2-h incubation, none of the discs
cultured with PD98059 stained with the doubly phosphor-
ylated-MAPK antibody, while control discs showed the
expected pattern (data not shown). When larval brains were
dissected from wildtype CS larvae at 10 h posthatching and
incubated without addition of PD98059, 27.0 0.7% of the
samples (10/37) had normal numbers of S-phase neuroblasts
16–20 h posthatching. In contrast, if CS brains were cul-
tured in 10 M PD98059 from 10–20 h posthatching, only
3  3% of the samples (1/36) had normal numbers of
S-phase neuroblasts at 16–20 h posthatching. These data
show that blocking MAPK activation at first instar also
blocks activation of cell division in arrested neuroblasts.
Trol interacts physically with FGF-2
To test whether FGF-2 binds to the Trol protein, coim-
munoprecipitation studies with Trol and FGF-2 were per-
formed (Fig. 4C). Third instar extracts were size-fraction-
ated to produce a 100-kDa aliquot enriched in Trol.
Addition of human 125I-FGF-2 to the extract and immuno-
precipitation of the resulting complex by an anti-mPerlecan
domain IV antibody revealed a radioactively labeled band
that migrated at approximately 20 kDa, the same position as
purified FGF-2 (data not shown). The addition of heparin
sulfate to the extract plus 125I-FGF-2 greatly reduced the
copurification of the 20-kDa band upon precipitation with
the anti-mPerlecan antibody. Little FGF-2 was isolated
when the extract plus 125I-FGF-2 was probed with an un-
related mouse antibody.
Hedgehog is an activator of neuroblast division
The effect of Hedgehog signaling on initiation of neuro-
blast proliferation was investigated by using hhts2 and hs-hh
lines (Fig. 5A). When larvae were reared at the mildly
Fig. 4. trol modulates FGF signaling. (A) Brain lobes of first instar larvae
were stained for BrdU incorporation from 16–20 h ph, and the number of
S-phase neuroblasts/brain lobe was quantitated and normalized to the
average control value. Heterozygosity for bnl06916 in a trolb22 background
results in fewer BrdU-labeled neuroblasts. (B) Percent of cultured samples
with normal levels of S-phase neuroblasts compared with controls in the
presence or absence of 10 ng/ml human FGF-2. (C) Co-IP of human FGF-2
with Trol. Lane (1) IP with anti-mPerlecan domain IV; (2) IP with anti-
mPerlecan domain IV in the presence of heparin; (3) IP with unrelated
mouse monoclonal.
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restrictive temperature of 25°C, all hhts2 animals had fewer
dividing neuroblasts (n  17) compared with sibling con-
trols (n 18). In contrast, 77% of homozygous hs-hh larvae
raised at 25°C contained excess dividing neuroblasts (n 
20/26). On average, the hs-hh samples with extra dividing
neuroblasts contained 62% more S-phase stem cells com-
pared with controls.
Hh and Shh proteins form a complex with Trol/Perlecan
Coimmunoprecipitation studies were used to determine
whether interactions could be detected between Hedgehog
proteins and Trol (Fig. 5B). Third instar larvae containing a
hs-hh construct were placed at 37°C for 30 min to induce
increased levels of Hh protein, and protein extracts were
prepared. The extracts were size fractionated for 100-kDa
particles and precipitated with an antibody raised against
mPerlecan domain IV, a nonspecific antibody, or no anti-
body at all. Western analysis of the purified complexes
using an anti-Hh antibody revealed a band in the sample
isolated using the anti-mPerlecan antibody. A much fainter
band was observed in the lane prepared without antibody
addition, and no band of the expected size was detected in
the sample purified using a nonspecific antibody. Addition
of heparin sulfate to the extract failed to reduce the intensity
of the Hh-immunoreactive band.
Studies were also carried out to identify possible inter-
actions between mPerlecan and mammalian Hh proteins
(Fig. 5B). Conditioned medium from highly confluent cul-
tures of different primary murine cerebrovascular endothe-
lial (CVE) cell lines derived from different strains of mice
(Sapatino et al., 1993) was analyzed. Protein complexes
from two cell lines were precipitated with the anti-mPerle-
can domain IV antibody or a nonspecific antibody, and the
resulting samples were analyzed by Western blotting. As
observed for Trol, lanes containing samples isolated with
the anti-mPerlecan antibody revealed a band of 32 kDa
when probed with an anti-Shh antibody (Fig. 5B), which is
Fig. 5. Hh signaling affects neuroblast proliferation. Brain lobes of first instar larvae were stained for BrdU incorporation from 16–20 h ph, and the number
of S-phase neuroblasts/brain lobe quantitated and normalized to the average control value. (A) Changing the level of hh expression affects the number of
S-phase neuroblasts. (B) Top panel: Co-IP of Hh with Trol. Lane (1) IP with no added antibody; (2) IP with anti-mPerlecan domain IV; (3) IP with
anti-mPerlecan domain IV plus heparin; (4) IP with unrelated mouse monoclonal. Bottom panel: Co-IP of Shh with Perlecan. Lane (5 and 6) IP with
anti-mPerlecan domain IV (7) IP with unrelated mouse monoclonal. (C) Heterozygosity for hh2 in a trolb22 background results in fewer BrdU-labeled
neuroblasts. (D) Heterozygosity for hhAC in a trolb22 background results in fewer BrdU-labeled neuroblasts. (E) trolb22; ttv00681/ brains have extra S-phase
neuroblasts. (F) trolb22; hh21/ brains and 18% of hh21/ brains also have supernumerary BrdU-labeled neuroblasts.
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not decreased in the presence of added heparin. Much less
signal was observed in lanes containing complexes isolated
with a nonspecific antibody.
Mutations in genes required for Hh signaling also
interact with trol alleles
To examine the possibility that trol modulates Hh-medi-
ated neuroblast activation, we examined the extent of stem
cell division in trolb22; hh2/ animals (Fig. 5C). All trolb22,
hh2/ samples showed decreased levels of neuroblast divi-
sion (n  24) compared with normal numbers of S-phase
neuroblasts in all control trolb22 and hh2/ (n 33 and n
24, respectively) samples. An increase in the severity of the
neuroblast proliferation phenotype in trol mutants heterozy-
gous for hh2 was also observed for the independent trol8
allele (data not shown). Similar results were obtained in
trolb22 and trol8 mutants with the protein null allele hhAC
(Fig. 5D; data not shown). As in the hh2 experiments, 100%
of the trolb22; hhAC/ animals had decreased neuroblast
division compared with control hhAC/ samples (n  22
and n  19, respectively). In trol8 mutants, 18% of the
samples show a proliferation defect (4/22). In contrast, 81%
of trol8; hhAC/ animals had decreased numbers of S-phase
neuroblasts compared with controls.
To verify that decreasing Hh signaling caused decreased
activation of neuroblast division in larval stages rather than
production of fewer neuroblasts in embryogenesis, we used
a temperature-sensitive hh allele, hhts2, to lower Hh activity
only in trolb22 first instar larvae. Egg lays and all of embry-
ogenesis were carried out at the permissive temperature of
18°C, and newly hatched larvae were collected in 1-h win-
dows and then moved to 25°C. All of the trolb22; hhts2/
samples showed decreased neuroblast proliferation (n 
12), while all trolb22/; hhts2/ siblings had normal cell
division (n  11).
Ttv, an exostose that synthesizes heparan sulfate chains,
is required for the reception of the Hh signal in cells of the
wing imaginal disc (Bellaiche et al., 1998; The et al., 1999;
Toyoda et al., 2000). We therefore examined the neuroblast
phenotype of trolb22; ttv00681/ animals (Fig. 5E). Every
trolb22; ttv00681/ sample showed supernumerary S-phase
neuroblasts, averaging 90% more neuroblasts/brain lobe (n
 13). In contrast, both trolb22 and ttv00681/ control sam-
ples showed normal neuroblast proliferation (n  15 and n
 23, respectively). The effect of one copy of ttv in a trol4
mutant background was also examined. In trol4 mutant
animals, excess S-phase neuroblasts are never observed
(0/44); however, in 29% of trol4; ttv00681/ samples, su-
pernumerary S-phase neuroblasts were detected (6/21) av-
eraging 21% more S-phase neuroblasts/brain lobe. In addi-
tion, 41% of trol4 mutant animals have decreased neuroblast
proliferation (18/44), while only 5% of trol4, ttv00681/
animals show a defective proliferation phenotype (1/21).
Hh signaling results in expression of its target gene ptc
(Alexandre et al., 1996), and expression of ptc as followed by
a ptc-LacZ transgene has been used previously as a reporter of
Hh signaling (Bellaiche et al., 1998; Chamoun et al., 2001;
Micchelli et al., 2002). We examined expression of ptc-lacZ in
first instar larval brains from trolb22; ttv00681/, trolb22, and
ttv00681/ animals to determine whether Hh signaling ex-
tended further or to more cells in trolb22; ttv00681/ animals
compared with controls (Fig. 6A). In all trolb22; ttv00681/
samples examined (n  10), stronger lacZ expression as fol-
lowed by -galactosidase activity staining was observed in the
posterior lateral portion of the brain lobes than in trolb22 (n 
8) or ttv00681/ (n  15) controls.
hh21 results in an over-proliferation phenotype and
produces a mutant protein
Genetic interaction studies with trolb22 and a second hh
allele, hh21, also revealed an overproliferation phenotype
(Fig. 5F). One-hundred percent of trolb22; hh21/ samples
contained excess S-phase neuroblasts, with an average of
94% more BrdU-labeled neuroblasts/brain lobe than in sib-
ling trolb22 controls (n  13 and n  9, respectively). The
overproliferation phenotype was also detected in 18% of
animals that are hh21/ (5/28). The excess BrdU-labeled
neuroblasts are likely to be due to a mutant Hh21 protein
derived from the hh21 allele as demonstrated by the results
from analysis of heterozygosity with hh2 and the protein
null allele hhAC.
Molecular analysis of hh21 revealed a mutant Hh precur-
sor and a processed amino-terminal protein species larger
than wildtype (data not shown). RT-PCR of RNA from
hh21/ and control y w third instar wing discs using primers
for the 3 two-thirds of the hh message produced the ex-
pected wildtype band of 730 bp and a larger band approx-
imately 850-900 bp in size in the hh21/ sample. Use of
additional primer pairs demonstrated that the inserted se-
quence is either 5 or immediately 3 to the DNA encoding
the autocleavage site (Porter et al., 1995) that separates the
amino-terminal signaling portion of the Hh protein from the
carboxy-terminal autoproteolytic portion of the Hh precur-
sor. The hh21/ genomic DNA revealed no inserted se-
quence. Use of an anti-HhN antibody against the amino
terminal fragment of the Hh protein (Porter et al., 1995) on
a Western blot of extract from stage 9–early stage 10
hh21/ and y w embryos detected a band of the expected
size for the wildtype Hh cleavage product with the signal
peptide attached (Lee et al., 1994) in the hh21/ and control
y w lanes and larger bands consistent with a mutant amino-
terminal Hh21 cleavage product with and without signal
peptide in the hh21/ lanes alone.
bnl and hh expression in larval brain lobes
bnl06916 and hhP30 lacZ reporter lines were used to assay
patterns of bnl and hh mRNA in first instar larval lobes. In
larvae at 4 h ph when the developmentally regulated neuro-
blasts are still mitotically quiescent, neither bnl- nor hh-driven
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-galactosidase activity is detectable (data not shown). In con-
trast, at 16-20 h ph when regulated neuroblasts are beginning
to synthesize DNA, both bnl- and hh-driven lacZ expression
are present (Fig. 6B). -Galactosidase activity stains reveal
low levels of bnl expression in the medial anterior portion of
the brain lobe, while hh is more robustly present in the lateral
posterior portion of the brain lobe.
Discussion
Mutations in trol arrest neuroblasts at G1
The severe partial loss-of-function mutation at trol, trolsd
(Data and Kankel, 1992) results in a dramatic drop in the
number of quiescent neuroblasts that activate cell division at
late first instar (Datta, 1995). Here, we have described the
isolation of several new trol alleles and characterization of
the neuroblast proliferation phenotype in three of them.
Mutations in three alleles result in defective activation of
neuroblast division, which can be rescued by expression of
cycE, indicating that trol function is likely to be involved in
the regulated progression of neuroblasts from mitotic qui-
escence through G1 to S.
trol encodes a gene similar in sequence to Perlecan
Several lines of evidence indicate that trol encodes the
Drosophila Perlecan protein. Due to the large size of the trol
message (greater than 13.5 kb) and Trol open reading frame
in genomic DNA (about 40 kb), we have not carried out
transformation and phenotypic rescue studies. However, the
identification of molecular lesions in the perlecan gene and
mRNA in four independent trol alleles, the changes in the
level of Trol protein in four independent mutants, and re-
sults from RNAi experiments strongly suggest that trol
encodes a protein with high similarity to mammalian Per-
lecan. While bands of altered mobility are observed in a
Western of the native gel from trolb22 samples, the trol7
allele presumably produces an unstable protein as little
immunoreactivity is detected in these extracts. Concomitant
with revision of this manuscript, Voigt et al. (2002) pub-
lished results confirming that trol encodes the Drosophila
Perlecan protein.
trol is expressed at all developmental stages, in the larval
brain, imaginal discs and fat body, and in the adult gonads
(Fig. 3). Friedrich et al. (2000) have also shown that RNA
encoding Perlecan domain V is expressed in the embryo and
imaginal discs. trol message is detectable in unfertilized
eggs (C.R. and S.D., data not shown), consistent with pre-
vious characterization of trol as a maternal effect gene
(Garcia-Bellido and Robbins, 1983). Voigt et al. (2002)
have also detected trol expression in cells of the late third
instar brain outside of the optic lobe region 3 days after the
onset of the trol neuroblast proliferation phenotype. Our
preliminary results suggest that Trol protein is present either
throughout or over the surface of the larval brain at first
Fig. 6. Gene expression in larval brains. First instar larval brains at 20 h ph were assayed for gene expression by using -galactosidase activity stain to follow
lacZ gene fusions. (A) ptc-lacZ expression in trolb22; ttv00681/ brain (top panel) and ttv00681/ control (bottom panel). (B) bnl-lacZ expression (top panel)
and hh-lacZ expression (bottom panel) in larval brains. In all panels, anterior is to the right. Scale bar indicates 25 m.
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instar (M. Boland and S.D., data not shown), the latter
would be consistent with in situ hybridization showing trol
mRNA at the basal surface of the embryonic CNS. This
distribution of Trol would allow interaction of Trol with Bnl
and Hh either near their sites of expression (Fig. 6B) or near
the quiescent neuroblasts, which are located at the cortical
surface of the larval brain.
trol is required for FGF signaling
Trol appears to display functions similar to mammalian
Perlecans, which are known to bind FGF-2 and to be re-
quired for FGF signaling. Dominant enhancement of the
neuroblast proliferation phenotype of two different trol al-
leles was observed with mutations in bnl (Fig. 4A) and the
Bnl receptor btl, but not with mutations in the orphan htl
receptor. The neuroblast proliferation phenotype of trol8
mutant brains was rescued in culture to control levels by
addition of human FGF-2 (Fig. 4B). Addition of the MAPK
inhibitor PD98059 at 10 hs post hatching decreased the
number of S-phase neuroblasts. Biochemical analysis
showed that FGF-2 can be coimmunoprecipitated with Trol
and that the binding of FGF-2 to Trol can be competed by
added heparin. This suggests that, like mPerlecan, Trol
binds FGF-2 through heparan sulfate residues. These results
demonstrate that Trol-mediated FGF signaling is required
for initiation of neuroblast proliferation sometime in first
larval instar. This similarity to the function of mPerlecans in
mammalian FGF signaling and the implications of up-reg-
ulation of mperlecan in tumors strongly imply that trol
encodes a functional Drosophila Perlecan homolog.
Hedgehog affects proliferation of neuroblasts
Hedgehog has been shown to affect stem cell division of
somatic stem cells in the Drosophila ovaries (Forbes et al.,
1996; King et al., 2001; Zhang and Kalderon, 2000, 2001).
In addition, blocking Sonic Hedgehog activity decreases the
number of neural crest stem cells in the chick (Ahlgren and
Bronner-Fraser, 1999), and Sonic hedgehog activity is re-
quired for proliferation of precursor cells in avian somites
(Marcelle et al., 1999) and murine spinal cord (Rowitch et
al., 1999). Here, we have demonstrated that loss of Hh using
a temperature-sensitive mutation results in fewer S-phase
neuroblasts at the time these cells begin to proliferate, while
production of Hh with an inducible hh gene almost doubles
the number of BrdU-labeled neuroblasts (Fig. 5A). While it
is possible that high levels of Hh actually cause apoptosis,
which is then repaired by increased neuroblast division, we
find this unlikely given that induction of the hs-hh transgene
rapidly produces excess S-phase neuroblasts (data not
shown). These results indicate that Hh is required to activate
stem cell division in quiescent larval neuroblasts and that
the level of Hh signaling may limit the number of neuro-
blasts capable of dividing.
trol functions in Hh signaling
Genetic interaction studies demonstrated that the weak
lethality of trolb22 is enhanced by mutations in hh or ptc, but
not wg (not shown). Thus, while trol is required for more
than one signaling pathway, there is specificity of trol func-
tion. Two independent mutations in hh dominantly enhance
the trol proliferation phenotype (Fig. 5C and D). Analysis of
a temperature-sensitive hh allele shows that, like FGF sig-
naling, Hh signaling is required in first instar for normal
activation of neuroblast division. Our biochemical studies
indicate a potential interaction between Perlecan and
Hedgehog proteins in both flies and mammals that is not
competed by added heparin (Fig. 5B). This contrasts with
FGF-mPerlecan and FGF-Trol interactions that are com-
peted with heparin (Whitelock et al., 1996, and this manu-
script). Thus, mammalian and Drosophila Perlecan may
form complexes with Hedgehog proteins. Future studies
will investigate the direct association between Perlecans and
Hedgehogs. Our genetic analyses and our initial biochemi-
cal study suggest that Trol modulates both Hh and FGF
signaling, perhaps through formation of a signaling com-
plex.
Possible competition between Hh movement and Hh
binding
Some hh21l animals (with normal copies of trol and ttv)
show extra BrdU-labeled neuroblasts, indicating that the
hh21 mutation results in increased Hh signaling (Fig. 5F).
The molecular basis for the hh21 mutation is likely an
altered splicing event resulting in an insertion in the portion
of the hh mRNA that encodes the signaling activity. Such a
mutation could affect the ability of the mutant Hh protein to
be processed and released from the cell surface. When
placed in a trolb22 background, all hh21l brains have al-
most twice as many BrdU-labeled neuroblasts as controls,
indicating that a mutation in trol increases the hyperactive
phenotype of the hh21 mutation.
Surprisingly, analysis of trolb22; ttv00681 brains yielded
supernumerary labeled neuroblasts (Fig. 5E) similar to
those observed in hs-hh samples. Analysis of expression of
the Hh target gene ptc in trolb22; ttv00681/ brains revealed
a higher level of ptc expression in the portions of the brain
expressing hh compared with controls (Fig. 6A and B). This
increase in ptc expression near the source of Hh suggests
that the combination of a mutation in trol and decrease of
Ttv activity results in higher levels of Hh signaling near
hh-expressing cells. A possible model to explain this obser-
vation is that when the function of trol is compromised,
movement of Hh away from the source of Hh production
competes with binding of Hh to nearby responding cells,
resulting in stronger signaling nearby and suggesting that
trol may function in the diffusion and/or reception of sig-
naling by Hh.
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Perlecans, HSPGs, signaling, and stem cell division
Taken together with previous studies, our results show
that both Drosophila and mPerlecans participate both as
structural components of basement membranes and as func-
tional components of the FGF-2 signaling pathway associ-
ated with cellular proliferation (reviewed in Olsen, 1999;
Caldwell and Datta, 1998; Datta, 1995, 1999; Datta and
Kankel, 1992; Park et al., 1998). In addition, here we pro-
vide the first evidence that Perlecans are also involved in
signaling by Hedgehog proteins, suggesting an alternative
interpretation of perlecan knock-out mouse phenotypes pre-
viously attributed to structural defects in extracellular ma-
trix (Costell et al., 1999). In mPerlecan null mice, chondro-
cyte division is altered, leading to disorganization of the
proliferative zone similar to that seen in the proliferation
zones of the optic lobe in third instar trol mutants (Datta and
Kankel, 1992). Altered patterns of chondrocyte proliferation
could be due to changes in FGF (Deng et al., 1996) and
Indian hedgehog (St-Jacques et al., 1999; Vortkamp et al.,
1996) signaling, correlating with altered neuroblast prolif-
eration in trol mutants with diminished FGF or Hh signal-
ing. Perlecan knockout mice have a gap between the pro-
liferative and hypertrophic zones, correlating with the gap
between the compound eye and adult optic lobe found in
adult trol mosaics (Datta and Kankel, 1992). These results
suggest that Trol/mPerlecan is integral to FGF and Hh
signaling and that these signals interface to regulate stem
cell proliferation and differentiation. This does not preclude,
however, a structural function in assuring the integrity of
basement membranes. Given that mPerlecan proteins are in
the 450-kDa range with a distinct “beads on a string” do-
main structure, it is possible that this versatile protein has
multiple developmental roles.
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